Skip to main content
Clinical Trials/NCT02466139
NCT02466139
Completed
Not Applicable

Early Clinical, Laboratory and Microbiological Predictors of Treatment Outcomes Among Infective Endocaridtis Patients in a Tertiary-care Centre in Kerala

Government Medical College, Kozhikode0 sites102 target enrollmentApril 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infective Endocarditis
Sponsor
Government Medical College, Kozhikode
Enrollment
102
Primary Endpoint
Major complications
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The investigators conduct a prospective observational study on consecutive patients being admitted to a tertiary care-centre with infective endocarditis. The investigators' primary aim is to identify baseline clincal, laboratory and microbiological predictors of in-hospital events, mortality and 6-month mortality.

Detailed Description

Mortality and major complications among infective endocarditis remain high. In addition developing nations are crippled with a high incidence of culture-negative endocarditis and lack of wide availability of transesophageal echocardiography. We intended to identify predictors among admission clinical features, laboratory paramters and culture reports that can help risk stratify patients early in the course of treatment.

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
April 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sandeep Mohanan

Senior Resident (DM) Cardiology

Government Medical College, Kozhikode

Eligibility Criteria

Inclusion Criteria

  • Fulfillment of modified Duke criteria

Exclusion Criteria

  • No consent
  • inadequate baseline data

Outcomes

Primary Outcomes

Major complications

Time Frame: 30 days

In-hospital mortality

Time Frame: 30 days

Secondary Outcomes

  • Short term Mortality(6 months)
  • Number of patients who needed urgent cardiac surgery(30 days)
  • Number of patients who had embolic events(30 days)

Similar Trials